ex12-Biosimilar adoption lags in the US compared to other countries (Copy)

Table with 6 columns and 9 rows.
	US¹
Bevacizumab	86	66	94	93	92
Trastuzumab	85	20	89	84	96
Rituximab	71	83	66	88	96
Infliximab	54	95	50	86	99
Pegfilgrastim	44	82	99	66	100
Insulin Glargine	28	15	48	17	32
Adalimumab	2	90	63	77	93
Etanercept	0	87	72	88	92
Average adoption	46%	69%	73%	74%	88%